{"id":"W2744261860","doi":"10.1182/blood-2017-03-769620","title":"Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1683,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Diffuse large B-cell lymphoma; Medicine; Ibrutinib; Lymphoma; Refractory (planetary science); Internal medicine; Leukemia; Chronic lymphocytic leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02363812012859347,"score_gpt":0.2921175936723523,"score_spread":0.2684794735437589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}